# quadraScope

quadraScope is a Private Equity based in Boston, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Founded:** 2022
- **Assets under management:** Undisclosed
- **Website:** www.quadrascope.com
- **LinkedIn:** https://www.linkedin.com/company/quadrascope-fund

## Regulatory record

- **CRD number:** 326749
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/326749

## About

quadraScope invests in healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices enabling disease treatment and prevention through biological age reversal. The firm is focused on the longevity healthcare and rejuvenation market, selecting and vetting investment opportunities in this emerging biotech sector.

## Sectors

- Digital Health
- Pharmaceuticals & Biotech
- Medical Devices

## Offices

- Tel Aviv, Israel

## People

- Fiona Miller — Operating Team
- José Navarro-Betancourt — Operating Team
- Eve Voronkina — Operating Team
- Nir Barzilai — Scientific Advisory Board
- Aubrey de Grey — Scientific Advisory Board
- Carmela Abraham — Scientific Advisory Board
- Robert Cargill — Scientific Advisory Board
- Diane Seimetz — Scientific Advisory Board
- Reason — Scientific Advisory Board
- Nikola Markov — Scientific Advisory Board
- Miri Polachek — Business Advisory Board
- Nico Helling — Business Advisory Board
- Frank Wellens — Business Advisory Board
- Daniel Fylstra — Business Advisory Board
- Lan Clark — Business Advisory Board
- José Cordeiro — Business Advisory Board
- Noriko Yokoi — Business Advisory Board

## Questions

### Who runs investment decisions at quadraScope?

Fiona Miller leads the firm, alongside operating team members José Navarro-Betancourt, MD, PhD, and Eve Voronkina. The firm also draws on a scientific advisory board that includes Nir Barzilai, MD, and Aubrey de Grey, PhD, to guide investment selection. Business advisory input comes from Miri Polachek and others.

### How does quadraScope source proprietary deal flow?

quadraScope cites strategic locations in Boston and Tel Aviv to leverage concentrations of biotech academia and industry. The firm also points to its scientific advisory board, which includes prominent geroscientists, as a filter for early-stage deal vetting.

### Does quadraScope participate in fund commitments or only direct deals?

Available public information describes quadraScope's activity exclusively in terms of direct deals into early-stage companies. Its website does not mention fund-of-funds commitments or co-investment vehicles.

### What investment stages does quadraScope typically target?

quadraScope targets early-stage companies, specifically Seed and Start-up stages. It puts capital into ventures developing pharmaceuticals, diagnostics, software, equipment, and devices for the longevity sector.

### How is quadraScope related to Repair Biotechnologies or Longevity Escape Velocity Foundation?

Reason, CEO of Repair Biotechnologies, serves on quadraScope's scientific advisory board and refers to the firm as an investor in his company. Aubrey de Grey, who also serves on the scientific advisory board, is President and CSO of the Longevity Escape Velocity Foundation and notes that he serves because of the quality of quadraScope's investment choices, including into his organizations.

### What is quadraScope's known posture on co-investments alongside external GPs?

quadraScope does not publicly discuss co-investment alongside external GPs. Its disclosed investment model is direct investing into early-stage longevity companies.

## Related profiles

- [Quadrant Private Equity](https://altss.com/profile/quadrant-private-equity)
- [Quadria Capital](https://altss.com/profile/quadria-capital-investment-management)

---

Last updated: 2026-08-11T15:07:49.000Z

Canonical page: https://altss.com/profile/quadrascope

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology